|
|
|
|
The Anatomical Therapeutic Chemical (ATC) classification system
|
|
|
|
|
|
Level 5
L - Antineoplastic and immunomodulating agentsL04 - Immunosuppressive agentsL04A - Immunosuppressive agentsL04AB - Tumor necrosis factor alpha (TNF-alpha) inhibitorsL04AB04 - Adalimumab
Adalimumab
|
|
|
|